Rays Power Infra announced closure of INR 127 Crore Equity Capital Fund Raise - RPG Art Foundation unveils ‘Overshoot — Leaning Ecologies’ at Nariman Point, MumbaiHon’ble Shri Rahul Narwekar, Speaker of the Maharashtra Legislative Assembly, inaugurates Arunkumar H G’s new public art installation - Gaja Alternative Asset Management Limited Announced it's Initial Public Offer (IPO) to open on Wednesday, August 19, 2026Price Band has been fixed from ₹ 152 to ₹ 160 per Equity Share - Horizon Industrial Parks Limited Announced its Initial Public Offer (IPO) to open on Monday, August 17, 2026 Price Band has been fixed at ₹ 57 to ₹ 60 per Equity Share - Shankesh Jewellers Limited Announced its Initial Public Offering (IPO) to open on Tuesday, August 18, 2026, Price Band fixed at ₹ 88 to ₹ 93 per equity share of the face value of ₹5 each - MILKY MIST DAIRY FOOD LIMITED ANNOUNCED ITS INITIAL PUBLIC OFFERING (IPO) OF EQUITY SHARES TO OPEN ON TUESDAY 11 AUGUST 2026Price Band fixed at ₹133 to ₹140 per equity share of face value of ₹2 each - Shiprocket Limited Announced it's Initial Public Offer (IPO) to open on Wednesday, August 12, 2026 Price Band has been fixed from ₹ 92 to ₹ 97 per Equity Share - Paramotor Digital Technology expands distribution of Digital Prepaid Payment Solutions with Aditya Birla Capital Digital products - Molbio Diagnostics Limited Announced its Initial public offering (IPO) to open on Monday, August 10, 2026 Price Band fixed at ₹ 768 per equity share of face value ₹1 each to ₹ 807 per equity share of the face value of ₹1 each - US Federal Contractor Tryfacta Achieves Final CMMC Level 2 (C3PAO) Certification, Strengthening Its Commitment to the U.S. Defense Industrial Base - Dhoot Transmission Limited Announced its Initial Public Offering (IPO) to open on Monday, August 10, 2026 Price Band fixed at ₹ 829 per equity share of face value ₹2 each to ₹871 per equity share of the face value of ₹2 each

Below 5 years babies to breathe easy with nebulisers having nasal aspirator function, Effective for clear nasal tract and both upper & lower airway treatment

Mumbai, Sep 07 2020 (GNI): Nasal congestion due to mucus secretion is a common issue among infants. However, despite the great advances made in medical technology, in majority of cases, the mucus formed is removed manually by parents, causing great discomfort to the child.

OMRON Healthcare India, the global leader in the field of clinically proven & innovative medical equipment for home health monitoring and therapy, backs the utility of nasal aspirator to help parents effectively manage such situations. “A nasal aspirator is gentle, more efficient, less invasive, and easier to use in comparison to manual methods including bulb syringe or saline drops. It’s very helpful in making the nasal tract clean for the baby which plays an important role in improving the eating and sleeping habits thus reducing the risk of developing other infections,” says Rohit Saini, GM-Sales and Marketing, OMRON Healthcare India.

The company has recently unveiled “DuoBaby”, a nebuliser cum nasal aspirator designed especially for new-born babies. The 2-in-1 device is India’s first-of-its-kind drug delivery device exclusively designed for treating respiratory ailments in babies aged between 0-5 years.

Accompanied with a full suite of accessories, the DuoBaby eases baby’s cough and nasal blockages, while treating upper and lower airway respiratory conditions. It is a path-breaking offering in the field of drug delivery devices for treatment of respiratory ailments (ranging from minor flus to asthmas and bronchitis) in babies.

As a responsible & discerning medical devices maker, OMRON identifies it as one of the most pertinent healthcare needs of the society. As per Rohit, “Along with the key value proposition, we have tried to bring in utmost convenience and utility so that the parents can reduce their visits to clinics decrease the chances of Covid exposure.”

About OMRON Healthcare India

Established in 2010, OMRON Healthcare India is a key player in the health care segment providing innovative medical technologies for Monitoring and Therapy. Equipped with OMRON’s competent “Bio-information Sensing” the portfolio comprises of home healthcare products such as blood pressure monitors, respiratory therapy devices, body fat monitors, digital thermometers, pain management devices, etc. OMRON Healthcare was the first to introduce manual and digital blood pressure units to the home healthcare market in the world. Today, OMRON has the highest market share in the home-use digital BP monitor in India and across the globe.

OMRON Duo Baby is available at OMRON Brandshop:

https://www.omronbrandshop.com/home-care/nebulizers/duobaby/

Be the first to comment on "Below 5 years babies to breathe easy with nebulisers having nasal aspirator function, Effective for clear nasal tract and both upper & lower airway treatment"

Leave a comment

Your email address will not be published.


*